Delivery of F18 pifluflostat (pylarify) unit doses
Ended Awarded Last action
- Contract number
- 36C25625F0291
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,218,921
Award facts
- Contract value 36% obligated
- $3,396,153.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$232,567 | |
| Exercise an Option | $725,744 | |
| Original award | $725,744 |
About this award
Veterans Integrated Service Network 16 issued a delivery order to Progenics Pharmaceuticals Inc. on July 14, 2025, for delivery of F-18 pifluflostat (PYLARIFY) unit doses with a ceiling value of $3,396,153.20.
The order is issued under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Progenics Pharmaceuticals Inc. is a division of Lantheus Medical Imaging, Inc. and operates as the sole authorized manufacturer of PYLARIFY, a radiopharmaceutical diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection.
Place of performance is North Billerica, Massachusetts. The order carries an ultimate completion date of September 29, 2026, and is priced on a firm fixed-price basis with no set-aside designation.
Quick answers
Who was awarded contract 36C25625F0291?
36C25625F0291 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 16 (Veterans Health Administration) on July 14, 2025.
How much is contract 36C25625F0291 worth?
The government has obligated $1,218,921 on 36C25625F0291. Its current value, with exercised options, is $3,396,153.
Is contract 36C25625F0291 an order under another contract?
Yes. 36C25625F0291 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25625F0291 competed?
The extent of competition for 36C25625F0291 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award